Hypertrophic pyloric stenosis following persistent pulmonary hypertension of the newborn: a case report and literature review

Table 1 Cases of hypertrophic pyloric stenosis following persistent pulmonary hypertension of the newborn or pulmonary hypertension

Study	Gestational age	Birth weight	Sex	PPHN or PH		HPS
Study	Gestational age	Birth weight	Sex	Cause	Treatment	Age at onset	Treatment
Brouwers et al. [10]	39 weeks	2990 g	Male	MAS	ECMO	13 days	Pyloromyotomy
Malwade et al. [11]	Unknown	3200 g	Male	MAS	Sildenafil^a	21 days	Pyloromyotomy
Present case	38 weeks	3140 g	Female	MAS	Inhaled NO^a Sildenafil^a Bosentan^a	15 days	Atropine^a Nitroglycerin^a
Robertson et al. [12]	37 weeks	3600 g	Male	CDH	Inhaled NO^a Epoprostenol Sildenafil^a	40 days	Pyloromyotomy
Robertson et al. [12]	38 weeks	3714 g	Female	CDH	–	47 days	Pyloromyotomy
Robertson et al. [12]	38 weeks	2800 g	Male	CDH	ECMO Prostaglandin Milrinone	73 days	Pyloromyotomy
Ravindra et al. [13]	Term	2500 g	Male	CHD	–	2 months	Pyloromyotomy

PPHN persistent pulmonary hypertension of the newborn, PH pulmonary hypertension, HPS hypertrophic pyloric stenosis, MAS meconium aspiration syndrome, CDH congenital diaphragmatic hernia, CHD congenital heart disease, ECMO extracorporeal membrane oxygenation, NO nitric oxide
^a treatment associated with nitric oxide

ISSN: 1471-2431